Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIIb Evaluation of the Efficacy and Safety of Two Methadone Titration Methods for the Treatment of Cancer-related Pain With Inadequate Pain Relief or Intolerable Side Effects When Treated With Level 3 Opioids.

NCT01793480 is registered in ClinicalTrials.gov with RECORDATI GROUP as lead sponsor.

NCT NCT01793480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01793480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIIb Evaluation of the Efficacy and Safety of Two Methadone Titration Methods for the Treatment of Cancer-related Pain With Inadequate Pain Relief or Intolerable Side Effects When Treated With Level 3 Opioids.
Lead sponsor
RECORDATI GROUP
Phase
Phase 3
Overall status
Completed
Start date
January 5, 2012
Completion date
August 31, 2014
Enrollment
146 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

pain related to cancer